Sclerotherapy Market Size Worth $1.2 Billion By 2026

According to a new report Global Sclerotherapy Market, published by KBV research, The Global Sclerotherapy Market size is expected to reach $1.2 billion by 2026, rising at a market growth of 7.9% CAGR during the forecast period.

The detergents segment has the largest market share in the year 2019 and is anticipated to reciprocate the prominent CAGR in the coming years. Additionally, The Chemical Irritants market is expected to witness highest CAGR of 8.8% during (2020 - 2026).

The liquid sclerotherapy segment has the highest market share in the year 2019 and is also reciprocating substantial CAGR over the forecast period. The foam sclerotherapy segment is countering the highest CAGR in the coming years. Foam sclerotherapy is mainly based on the air-block technique in which a small air bubble is injected into the target vessel followed by injection of sclerosant in the center of the bubble.

North America led the market in the year 2019 and is anticipated to showcase a substantial CAGR in the foreseeable period. In Asia Pacific, the sclerotherapy market is anticipated to show the highest growth over the forecast period owed to the increasing geriatric population and adoption of sedentary lifestyle in the developing countries, such as India and China. In countries such as China, more than 100.0 million people are suffering from varicosities and most of them are affected with varicose veins in the lower limbs. These are some of the factors that are anticipated to boost the market in the region over the foreseeable period.

Structural Insights: https://www.kbvresearch.com/sclerotherapy-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Boston Scientific Corporation, Perrigo Company PLC (Omega Pharmaceuticals), Cook Medical, Inc. (Cook Group), Chemische Fabrik Kreussler & Co. GmbH, LGM Pharma, LLC, Troikaa Pharmaceuticals Limited, Tianyu Chang’an Group, Endo-Flex GmbH (Meditek Systems), Merz Pharma GmbH & Co. KGaA, and MTW-Endoskopie W. Haag KG.

Global Sclerotherapy Market Segmentation

By Agent

• Detergents
• Osmotic Agents
• Chemical Irritants

By Type

• Liquid Sclerotherapy
• Ultrasound Sclerotherapy
• Foam Sclerotherapy

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Boston Scientific Corporation
• Perrigo Company PLC (Omega Pharmaceuticals)
• Cook Medical, Inc. (Cook Group)
• Chemische Fabrik Kreussler & Co. GmbH
• LGM Pharma, LLC
• Troikaa Pharmaceuticals Limited
• Tianyu Chang’an Group
• Endo-Flex GmbH (Meditek Systems)
• Merz Pharma GmbH & Co. KGaA
• MTW-Endoskopie W. Haag KG

Unique Offerings from KBV Research

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Sclerotherapy Market Related Reports:

North America Market

Europe Market

Asia Pacific Market

LAMEA Market